Relatório de inteligência

Isomorphic Labs secures $5bn Series C co-led by Sequoia and Greenoaks

The DeepMind spin-out's new round lands six months after a $2.1bn Series B and will fund its move toward clinical trials.

INSIGHTEX Editorial Desk

2 min de leitura

Isomorphic Labs secures $5bn Series C co-led by Sequoia and GreenoaksRelatório de inteligência

What happened

Isomorphic Labs, the London-headquartered AI drug discovery company founded by Demis Hassabis, has closed a $5bn Series C round, Tech.eu reported. The raise comes six months after the company completed a $2.1bn Series B. California venture firms Greenoaks and Sequoia co-led the deal, joined by Andreessen Horowitz, Thrive Capital, Alphabet, Alphabet's GV and CapitalG, Temasek and the Sovereign AI fund.

The company said the capital will support further AI development and the build-out of clinical development infrastructure as it moves drug candidates into clinical trials. It plans to keep improving IsoDDE, its proprietary drug design engine, push into new areas of biology with more advanced models, and form a network of partners aimed at better understanding the mechanisms of disease.

Hassabis, who is also chief executive, said the round would help the company develop foundational biology models, deepen its understanding of disease at a systemic level and advance its first therapeutic programs to the clinic. President Max Jaderberg said the company's models were producing repeatable scientific gains each week that translate into improved molecular profiles for potential medicines.

Context

Isomorphic was spun out of Google DeepMind and draws on software developed there, including AlphaFold, the Nobel Prize-winning system that predicts protein structures. Its research focuses on cancer and immune disorders, and it is scaling both IsoDDE and a pipeline of AI-designed therapeutic candidates.

Andreessen Horowitz profile

Google profile

FonteTech.eu

O briefing

A semana em tecnologia, em um só e-mail.

As reportagens que valem o seu tempo, toda semana. Cancele quando quiser.